27 references, page 1 of 2
Sauer, R., Becker, H., Hohenberger, W.. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004; 351: 1731-1740 [PubMed]
Baglan, K.L., Frazier, R.C., Yan, D., Huang, R.R., Martinez, A.A., Robertson, J.M.. The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2002; 52: 176-183 [PubMed]
Robertson, J.M., Lockman, D., Yan, D., Wallace, M.. The dose-volume relationship of small bowel irradiation and acute grade 3 diarrhea during chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2008; 70: 413-418 [PubMed]
Tho, L.M., Glegg, M., Paterson, J.. Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: Investigating dose-volume relationships and role for inverse planning. Int J Radiat Oncol Biol Phys. 2006; 66: 505-513 [OpenAIRE] [PubMed]
Arbea, L., Ramos, L.I., Martinez-Monge, R., Moreno, M., Aristu, J.. Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): Dosimetric comparison and clinical implications. Radiat Oncol. 2010; 5: 17 [OpenAIRE] [PubMed]
Mok, H., Crane, C.H., Palmer, M.B.. Intensity modulated radiation therapy (IMRT): Differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma. Radiat Oncol. 2011; 6: 63 [OpenAIRE] [PubMed]
Jabbour, S.K., Patel, S., Herman, J.M.. Intensity-modulated radiation therapy for rectal carcinoma can reduce treatment breaks and emergency department visits. Int J Surg Oncol. 2012; 891067: 2012
Parekh, A., Truong, M.T., Pashtan, I.. Acute gastrointestinal toxicity and tumor response with preoperative intensity modulated radiation therapy for rectal cancer. Gastrointest Cancer Res. 2013; 6: 137-143 [OpenAIRE] [PubMed]
Yang, T.J., Oh, J.H., Son, C.H.. Predictors of acute gastrointestinal toxicity during pelvic chemoradiotherapy in patients with rectal cancer. Gastrointest Cancer Res. 2013; 6: 129-136 [OpenAIRE] [PubMed]
Gerard, J.P., Chapet, O., Nemoz, C.. Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: The lyon R96-02 randomized trial. J Clin Oncol. 2004; 22: 2404-2409 [PubMed]
Gerard, J.P., Azria, D., Gourgou-Bourgade, S.. Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: Results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol. 2010; 28: 1638-1644 [PubMed]
Hartley, A., Ho, K.F., McConkey, C., Geh, J.I.. Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: Analysis of phase II/III trials. Br J Radiol. 2005; 78: 934-938 [OpenAIRE] [PubMed]
Kachnic, L.A., Winter, K.A., Myerson, R.J.. RTOG 0529: A phase II evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys. 2013; 86: 27-33 [OpenAIRE] [PubMed]
Charlson, M.E., Pompei, P., Ales, K.L., MacKenzie, C.R.. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987; 40: 373-383 [OpenAIRE] [PubMed]
Guadagnolo, B.A., Liu, C.C., Cormier, J.N., Du, X.L.. Evaluation of trends in the use of intensity-modulated radiotherapy for head and neck cancer from 2000 through 2005: Socioeconomic disparity and geographic variation in a large population-based cohort. Cancer. 2010; 116: 3505-3512 [PubMed]
27 references, page 1 of 2